AI assistant
Sending…
ADMA BIOLOGICS, INC. — Director's Dealing 2012
Jul 26, 2012
31261_dirs_2012-07-25_3940a412-374e-4b2e-b9c9-c4e6a66cd60e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ADMA BIOLOGICS, INC. (NONE)
CIK: 0001368514
Period of Report: 2012-07-18
Reporting Person: Mond James (CSO/CMO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No securities are beneficially owned | 0 | Direct |
More from ADMA BIOLOGICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 2
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 15
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 3